SEARCH
Search Details
Ohya Shuuki
Division of Hematology & Oncology Department of Internal Medicine
Assistant Professor
Research activity information
■ Paper
- High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia.
Shuki Oya; Hidetoshi Ozawa; Satoshi Morishige; Yoshimi Maehiro; Masahiro Umeda; Yusuke Takaki; Toshinobu Fukuyama; Yoshitaka Yamasaki; Takayuki Nakamura; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Koji Nagafuji
International journal of hematology, Sep. 2024 - CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity.
Shuki Oya; Hidetoshi Ozawa; Takayuki Nakamura; Akira Mori; Sorahiko Ochi; Yoshimi Maehiro; Masahiro Umeda; Yusuke Takaki; Toshinobu Fukuyama; Yoshitaka Yamasaki; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Koji Nagafuji
International journal of hematology, Aug. 2024 - Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies.
Takayuki Nakamura; Shuki Oya; Hidetoshi Ozawa; Yoshimi Maehiro; Seiya Muta; Masahiro Umeda; Yusuke Takaki; Toshinobu Fukuyama; Yoshitaka Yamasaki; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Yoshiki Naito; Koji Nagafuji
International journal of hematology, Apr. 2024 - [Successful immunosuppressive therapy in female hemophilia A developing inhibitor after perioperative administration of factor VIII products].
Maki Yamaguchi; Yusuke Takaki; Yoshitaka Yamasaki; Shuki Oya; Takayuki Nakamura; Satoshi Morishige; Kazutoshi Aoyama; Fumihiko Mouri; Ryuta Takase; Yoko Matsuo; Koichi Osaki; Koji Nagafuji; Takashi Okamura
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2024 - [Successful induction therapy for acute myeloid leukemia under management with extracorporeal membrane oxygenation].
Yusuke Takaki; Toshiyuki Yanai; Tatsuhiro Shibata; Takehiro Honma; Maki Otsuka; Yoshitaka Yamasaki; Shuki Oya; Takayuki Nakamura; Yoshimi Maehiro; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Yoshihiro Fukumoto; Koji Nagafuji
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2024 - Alternating venetoclax/azacytidine and FLT3 inhibitor treatment for NPM1- and FLT3-mutated acute myeloid leukemia.
Shuki Oya; Hidetoshi Ozawa; Yoshimi Maehiro; Takayuki Nakamura; Yusuke Takaki; Toshinobu Fukuyama; Yoshitaka Yamasaki; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Koji Nagafuji
Leukemia research, Jul. 2023 - Severe drug-induced immune hemolytic anemia due to cefmetazole: A case report.
Masafumi Fukuda; Masakazu Nabeta; Shuki Oya; Osamu Takasu
International journal of clinical pharmacology and therapeutics, Jan. 2022 - [Allogeneic hematopoietic stem cell transplantations for relapsed and refractory acute lymphoblastic leukemia following inotuzumab ozogamicin treatment].
Satoshi Morishige; Yoshitaka Yamasaki; Shuki Oya; Takayuki Nakamura; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Yasuko Mizushima; Osamu Nakashima; Koji Nagafuji
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2022 - [FLT3-ITD and NPM1 mutation positive acute myeloid leukemia with cuplike blasts mimicking acute promyelocytic leukemia].
Kazutoshi Aoyama; Yoshitaka Yamasaki; Fumihiko Mouri; Yoshimi Maehiro; Yusuke Takaki; Shuki Oya; Takayuki Nakamura; Satoshi Morishige; Maki Yamaguchi; Koji Nagafuji
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2022 - A case of lymphomatoid granulomatosis with central nervous system involvement successfully treated with IFNα.
Yoshitaka Yamasaki; Satoshi Morishige; Satoru Komaki; Takuya Furuta; Hiroshi Koga; Shuki Oya; Takayuki Nakamura; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Koichi Osaki; Takekuni Nakama; Koichi Ohshima; Motohiro Morioka; Koji Nagafuji
International journal of hematology, Oct. 2021 - Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
Shuki Oya; Satoshi Morishige; Hidetoshi Ozawa; Kensuke Sasaki; Yuichiro Semba; Yoshitaka Yamasaki; Takayuki Nakamura; Kazutoshi Aoyama; Ritsuko Seki; Fumihiko Mouri; Koichi Osaki; Toshihiro Miyamoto; Takahiro Maeda; Koji Nagafuji
International journal of hematology, Feb. 2021 - Risks of Muscle Atrophy in Patients with Malignant Lymphoma after Autologous Stem Cell Transplantation.
Keisuke Hirota; Hiroo Matsuse; Shunji Koya; Ryuki Hashida; Masafumi Bekki; Yoko Yanaga; Kiyoko Johzaki; Mami Tomino; Fumihiko Mouri; Satoshi Morishige; Shuki Oya; Yoshitaka Yamasaki; Koji Nagafuji; Naoto Shiba
Physical therapy research, 2021 - Successful correction of factor V deficiency of patient-derived iPSCs by CRISPR/Cas9-mediated gene editing.
Takayuki Nakamura; Satoshi Morishige; Hidetoshi Ozawa; Kenji Kuboyama; Yoshitaka Yamasaki; Shuki Oya; Maki Yamaguchi; Kazutoshi Aoyama; Ritsuko Seki; Fumihiko Mouri; Koichi Osaki; Takashi Okamura; Shinichi Mizuno; Koji Nagafuji
Haemophilia : the official journal of the World Federation of Hemophilia, Sep. 2020 - [Interleukin-6-producing paraganglioma mimicking multicentric Castleman disease].
Shuki Oya; Yoshitaka Yamasaki; Takayuki Nakamura; Satoshi Morishige; Maki Yamaguchi; Kazutoshi Aoyama; Ritsuko Seki; Humihiko Mouri; Koichi Osaki; Yoshiki Naito; Koichi Oshima; Koji Nagafuji
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2020 - Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.
Satoshi Morishige; Marina Nishi; Hiroshi Saruta; Fumiko Arakawa; Yoshitaka Yamasaki; Shuki Oya; Takayuki Nakamura; Ritsuko Seki; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Koichi Osaki; Koichi Ohshima; Koji Nagafuji
International journal of hematology, Oct. 2019 - Breakthrough infection of Geotrichum capitatum during empirical caspofungin therapy after umbilical cord blood transplantation.
Shuki Oya; Tsuyoshi Muta
International journal of hematology, Nov. 2018
- 造血幹細胞移植後における血流感染症の発生率とそのリスク因子(Incidence and risk factors for bloodstream infections after hematopoietic stem cell transplantation)
森重 聡; 山崎 嘉孝; 大屋 周期; 中村 剛之; 山口 真紀; 関 律子; 青山 一利; 毛利 文彦; 大崎 浩一; 長藤 宏司
臨床血液, Sep. 2018 - 末梢性T細胞リンパ腫における中枢神経系再発 単施設での経験(Central nervous system relapse in peripheral T-cell lymphoma, a single institute experience)
毛利 文彦; 山崎 嘉孝; 大屋 周期; 森重 聡; 山口 真紀; 野波 篤; 関 律子; 大崎 浩一; 長藤 宏司
臨床血液, Sep. 2018 - 同種造血幹細胞移植後のサイトメガロウイルス再活性化に関する単一施設における検討(A retrospective analysis of cytomegalovirus reactivation after allogeneic stem cell transplantation)
大屋 周期; 森重 聡; 山崎 嘉孝; 中村 剛之; 青山 一利; 山口 真紀; 関 律子; 毛利 文彦; 大崎 浩一; 長藤 宏司
臨床血液, Sep. 2018 - 移植後シクロフォスファミド時代の同種幹細胞移植後ウイルス関連出血性膀胱炎の危険因子の検討(Risk factors of virus-associated hemorrhagic cystitis following allo-SCT in post-HSCT CY era)
青山 一利; 森重 聡; 山崎 嘉孝; 大屋 周期; 中村 剛之; 山口 真紀; 野波 篤; 毛利 文彦; 関 律子; 大崎 浩一; 長藤 宏司
臨床血液, Sep. 2018 - CRISPR/Cas9による一塩基編集iPS細胞を用いた新規SNP機能解析システム(CRISPR/Cas9 mediated single-base-edited iPSCs: a novel system for functional analysis of SNPs)
中村 剛之; 水野 晋一; 小澤 秀俊; 森重 聡; 山崎 嘉孝; 大屋 周期; 山口 真紀; 青山 一利; 関 律子; 毛利 文彦; 大崎 浩一; 岡村 孝; 長藤 宏司
臨床血液, Sep. 2018 - 治療抵抗性の急性前骨髄球性白血病(Refractory acute promyelocytic leukemia in adults)
山崎 嘉孝; 大屋 周期; 中村 剛之; 森重 聡; 山口 真紀; 青山 一利; 毛利 文彦; 関 律子; 大崎 浩一; 長藤 宏司
臨床血液, Sep. 2018 - 中枢神経浸潤をきたした多発性骨髄腫症例の後方視的検討(Multiple myeloma and central nervous system involvement: experience of Kurume University)
関 律子; 山崎 嘉孝; 大屋 周期; 中村 剛之; 森重 聡; 青山 一利; 山口 真紀; 毛利 文彦; 野波 篤; 大崎 浩一; 大島 孝一; 岡村 孝; 長藤 宏司
臨床血液, Sep. 2018 - イブルチニブ投与後に末梢血リンパ球が著明に増加した再発難治性マントル細胞リンパ腫
大屋 周期; 大崎 浩一; 籠手田 聡子; 中村 剛之; 森重 聡; 野波 篤; 関 律子; 毛利 文彦; 長藤 宏司
臨床血液, Jun. 2017 - Aggressive PTCL-NOS with CD4+CD56+cytotoxic molecule+の1例
吉弘 知恭; 牟田 毅; 大屋 周期; 青木 健一; 幸地 祐; 陳之内 文昭; 島 隆宏; 菊繁 吉謙; 竹中 克斗; 大島 孝一; 小川 亮介
臨床血液, Jun. 2016 - 寛解後早期にtherapy-related acute myelocytic leukemiaを発症したacute promyelocytic leukemiaの1例
大屋 周期; 青木 健一; 牟田 毅; 小川 亮介
臨床血液, Jun. 2016 - Lenalidomide+Dex療法中に結核性脳膿瘍を合併した再発性多発性骨髄腫
大屋 周期; 小川 亮介; 青木 健一; 平野 元; 牧山 明資; 牟田 毅; 連 乃駿; 伊野波 諭
臨床血液, May 2015
